Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Research article

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

Hidenori Toyoda, Takashi Kumada*, Noritomo Shimada, Koichi Takaguchi, Tatsuya Ide, Michio Sata, Hiroyuki Ginba, Kazuhiro Matsuyama and Namiki Izumi

BMC Infectious Diseases 2012, 12:324  doi:10.1186/1471-2334-12-324


  • Last 30 days: 30 accesses
  • Last 365 days: 566 accesses
  • All time: 1388 accesses